| 1 |
33147611 | A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma. | 2021 Feb 8 |
3 |
| 2 |
34040446 | A Community Hospital-Based Study: A Prespecified Neutrophil Count with Adjuvant mFOLFOX6 Associated with Increased Delays, Increased G-CSF Use, and Reduced Dose Intensity. | 2021 |
1 |
| 3 |
29086459 | Epidermal Growth Factor and Granulocyte Colony Stimulating Factor Signaling Are Synergistic for Hematopoietic Regeneration. | 2018 Feb |
1 |
| 4 |
29948238 | Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. | 2018 Dec |
2 |
| 5 |
28011495 | Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature. | 2017 Jan |
2 |
| 6 |
24595405 | Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. | 2014 Aug |
2 |
| 7 |
24821366 | Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study. | 2014 Oct |
1 |
| 8 |
23749899 | Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. | 2013 Jun |
1 |
| 9 |
17453364 | Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer. | 2007 |
2 |
| 10 |
17716984 | A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes. | 2007 Oct |
2 |
| 11 |
16520664 | Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study. | 2006 Mar |
1 |
| 12 |
12123334 | A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer. | 2002 Jun |
2 |
| 13 |
11304774 | Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group. | 2001 Apr 15 |
1 |
| 14 |
11404490 | Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer. | 2001 Jun |
2 |
| 15 |
9636831 | Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401. | 1998 Apr |
1 |
| 16 |
9662268 | IL-12 indirectly enhances proliferation of 5-FU-treated human hematopoietic peripheral blood CD34+ cells. | 1998 Jul |
2 |
| 17 |
9845529 | Human granulocyte colony-stimulating factor (G-CSF) stimulates the in vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor. | 1998 Dec 15 |
1 |
| 18 |
9217040 | Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. | 1997 Jul 15 |
1 |
| 19 |
8742097 | Different doses of granulocyte colony stimulating factor to support a weekly chemotherapeutic regimen in advanced gastric cancer: a randomized study. | 1996 Jan |
2 |
| 20 |
7538704 | Intensive weekly chemotherapy for elderly gastric cancer patients, using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and glutathione with the support of G-CSF. | 1995 Jan-Feb |
1 |
| 21 |
7525886 | Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. | 1994 Nov |
1 |
| 22 |
7683729 | Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression? | 1993 May 19 |
1 |
| 23 |
1280628 | Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice. | 1992 Oct |
1 |
| 24 |
2473792 | Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF. | 1989 Jul |
1 |
| 25 |
3491641 | Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil. | 1987 Jan |
1 |
| 26 |
3499607 | Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. | 1987 Oct |
2 |